{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:07:54Z","timestamp":1788898074424,"version":"build-2803163510"},"reference-count":18,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Public Health Surveill"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This research letter compared the prevalence of qualifying conditions among patients certified to use medical cannabis in Florida to population-based prevalence estimates for the same conditions and observed marked discrepancies. These findings highlight conditions that appear to be significant reasons for patients to consider medical cannabis, providing important research priorities for future research on its effectiveness and safety.<\/jats:p>","DOI":"10.2196\/89716","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:41:01Z","timestamp":1788896461000},"page":"e89716-e89716","source":"Crossref","is-referenced-by-count":0,"title":["Indications for Medical Cannabis and Their Alignment With US-Wide Disease Prevalences in the US\u2019 Largest Medical Cannabis Program: Cross-Sectional Study"],"prefix":"10.2196","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1244-1423","authenticated-orcid":false,"given":"Sebastian","family":"Jugl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0866-4579","authenticated-orcid":false,"given":"Nicole E","family":"Smolinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9688-8981","authenticated-orcid":false,"given":"Tansu Miriam I\u015f\u0131lay","family":"Aydo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6518-5961","authenticated-orcid":false,"given":"Almut G","family":"Winterstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"R1","unstructured":"Trends of registered patients, authorized physicians, and dispensing of medical marijuana. Consortium for Medical Marijuana Clinical Outcomes Research. 2021. URL: https:\/\/mmjoutcomes.org\/evidence\/medical-marijuana-utilization\/ [Accessed 15-11-2024]"},{"issue":"7","key":"R2","doi-asserted-by":"publisher","first-page":"945","DOI":"10.7326\/M22-0217","article-title":"U.S. Trends in registration for medical cannabis and reasons for use from 2016 to 2020: an observational study","volume":"175","author":"Boehnke","journal-title":"Ann Intern Med"},{"key":"R3","unstructured":"Project MP. Medical cannabis patient numbers. MPP. URL: https:\/\/www.mpp.org\/issues\/medical-marijuana\/state-by-state-medical-marijuana-laws\/medical-marijuana-patient-numbers\/ [Accessed 07-11-2025]"},{"key":"R4","doi-asserted-by":"crossref","unstructured":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. National Academies Press; 2017. [doi: 10.17226\/24625] ISBN: 978-0-309-45304-2","DOI":"10.17226\/24625"},{"issue":"1","key":"R5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000515069","article-title":"A mapping literature review of medical cannabis clinical outcomes and quality of evidence in approved conditions in the USA from 2016 to 2019","volume":"4","author":"Jugl","journal-title":"Med Cannabis Cannabinoids"},{"key":"R6","unstructured":"Cannabis policy impacts public health and health equity. National Academies of Sciences, Engineering, and Medicine. The National Academies Press; 2024. URL: https:\/\/www.nationalacademies.org\/read\/27766\/chapter\/1#ii [Accessed 12-08-2026]"},{"issue":"4","key":"R7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.7326\/M23-2811","article-title":"Trends in U.S. medical cannabis registrations, authorizing clinicians, and reasons for use from 2020 to 2022","volume":"177","author":"Boehnke","journal-title":"Ann Intern Med"},{"key":"R8","unstructured":"Tools for visualizing the GLOBOCAN cancer estimates in 2024. International Agency for Research on Cancer. URL: https:\/\/gco.iarc.who.int\/today\/ [Accessed 13-05-2026]"},{"key":"R9","unstructured":"Behavioral risk factor surveillance system (BRFSS) dashboard. FLHealthCharts. URL: https:\/\/www.flhealthcharts.gov\/ChartsDashboards\/rdPage.aspx?rdReport=BRFSS.Dataviewer&bid=0148 [Accessed 20-05-2026]"},{"issue":"11","key":"R10","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jamaophthalmol.2024.3884","article-title":"Prevalence of glaucoma among US Adults in 2022","volume":"142","author":"Ehrlich","journal-title":"JAMA Ophthalmol"},{"key":"R11","unstructured":"NCHHSTP atlasplus: tables. Centers for Disease Control and Prevention. URL: https:\/\/gis.cdc.gov\/grasp\/nchhstpatlas\/tables.html [Accessed 13-05-2026]"},{"issue":"8","key":"R12","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00127-016-1208-5","article-title":"The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III","volume":"51","author":"Goldstein","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"7-8","key":"R13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/21678421.2024.2358786","article-title":"Prevalence of ALS in all 50 states in the United States, data from the National ALS Registry, 2011-2018","volume":"25","author":"Mehta","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"issue":"5","key":"R14","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1053\/j.gastro.2023.07.003","article-title":"Incidence, prevalence, and racial and ethnic distribution of inflammatory bowel disease in the United States","volume":"165","author":"Lewis","journal-title":"Gastroenterology"},{"key":"R15","unstructured":"The Lewin Group. Economic burden of Parkinson\u2019s and atypical parkinsonism in the United States. URL: https:\/\/www.michaeljfox.org\/sites\/default\/files\/media\/document\/Economic%20Burden%20of%20Parkinson%E2%80%99s%20and%20Atypical%20Parkinsonism%20in%20the%20United%20States_0.pdf [Accessed 13-05-2026]"},{"issue":"10","key":"R16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000007035","article-title":"The prevalence of MS in the United States","volume":"92","author":"Wallin","journal-title":"Neurology"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.15620\/cdc\/169630","article-title":"Chronic Pain and High-impact Chronic Pain in U.S. Adults, 2023","author":"Lucas","journal-title":"NCHS Data Brief"},{"issue":"19","key":"R18","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1001\/jama.279.19.1548","article-title":"Why patients use alternative medicine: results of a national study","volume":"279","author":"Astin","journal-title":"JAMA"}],"container-title":["JMIR Public Health and Surveillance"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:41:03Z","timestamp":1788896463000},"score":1,"resource":{"primary":{"URL":"https:\/\/publichealth.jmir.org\/2026\/1\/e89716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":18,"URL":"https:\/\/doi.org\/10.2196\/89716","relation":{},"ISSN":["2369-2960"],"issn-type":[{"value":"2369-2960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"article-number":"v12i7e89716"}}